Novo Nordisk’s sales increased by 25% in Danish kroner and by 26% at constant exchange rates to DKK 290.4 billion in 2024
5/2 07:30
Bagsværd, 5 February 2025 – Financial report for the period 1 January 2024 to 31 December 2024 Operating profit increased by 25% in Danish kroner and by...
Læs mere »...